An in situ enzyme-linked immunosorbent assay was developed to measure in vitro development of Eimeria tenella. The assay used a polyclonal, anti-merozoite serum produced by immunization with culture-derived, chromatographically purified merozoites. Although this antiserum cross-reacted with sporozoite-infected cultures (by indirect immunofluorescence and in situ enzyme-linked immunosorbent assay), it clearly distinguished the increase in antigen synthesized throughout intracellular growth. The assay can be used for high-throughput, anticoccidial drug screening, for which it gives quantitative results that are comparable to the published radiometric ([3H]uracil incorporation) endpoint.The demonstration that asexual stages of Eimeria tenella could be cultivated in vitro (18) made possible the design of cell culture screens to identify anticoccidial drugs. The first screens described (24) used microscopic observation to score parasite development, a method that was both laborious and qualitative. A more efficient screen endpoint has been described by Schmatz et al. (23), who measured parasite-specific incorporation of [5,6-3H]uracil to quantitate parasite growth. The most labor-intensive step in this radiometric scoring method is the processing of samples for liquid scintillation counting. I describe an alternative scoring method using a colorimetric, in situ enzyme-linked immunosorbent assay (ELISA) which is less laborious and should further improve the efficiency of anticoccidial screening in vitro.Although ELISAs have been applied to studies of E. tenella (3,9,16,17,21), the methods are not adapted to measuring parasite growth. Instead, they are designed to quantitate the antibody produced in response to infection by using a fixed amount of parasite extract as an antigen. In situ ELISAs have been developed to measure in vitro growth and drug inhibition in virus-infected (1, 2, 11, 20) and protozoan-infected (6, 7, 13) monolayers. These assays detect growth of the infectious agent by measuring the antigen with a fixed amount of antibody specific for the infectious agent. This study was designed to adapt in situ ELISA methods to an E. tenella in vitro model.
MATERIALS AND METHODSAbbreviations. BSA, Bovine serum albumin; IC50, drug concentration producing 50% inhibition of growth; MDBK, Madin-Darby bovine kidney; OD405, optical density at 405 nm; PBS, phosphate-buffered saline.In vitro production of merozoites. MDBK cells (ATCC CCL 22) were grown in continuous culture at 40°C in 3% CO2 in nutrient mixture F12 (no. 320-1765, GIBCO Diagnostics) with 10% (vol/vol) fetal bovine serum (no. 110-1120, J. R. Scientific) and penicillin-streptomycin (no. 600-5140, GIBCO). Prior to infection, cells were subcultured into 175-cm2 flasks in RPMI 1640 (no. 320-1875, GIBCO) with 5% fetal bovine serum (RPSS). When MDBK cells had reached confluence, purified E. tenella sporozoites (22) were added at 2.5 x 105/cm2 in RP5S. After 24 h of incubation at 40°C to allow invasion, uninvaded sporozoites were removed by agitating the flask, r...